{
    "clinical_study": {
        "@rank": "148136", 
        "acronym": "BENTLEY", 
        "arm_group": {
            "arm_group_label": "TheraTears lubricating drops", 
            "arm_group_type": "Experimental", 
            "description": "TheraTears lubricating eye drops to be used 1 drop in both eyes four times a day (QID)"
        }, 
        "brief_summary": {
            "textblock": "The objective of the study is to see if there is a change in tear osmolarity over time when\n      moderate to severe dry eye subjects are treated with TheraTears\u00ae lubricating drops."
        }, 
        "brief_title": "Changes in Tear Osmolarity Over Time With Sustained Use of TheraTears", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Dry Eye Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Dry Eye Syndromes", 
                "Keratoconjunctivitis Sicca"
            ]
        }, 
        "detailed_description": {
            "textblock": "The hypothesis is that the measured tear osmolarity from study participants decrease with\n      sustained use of a over-the-counter artificial tears, TheraTears\u00ae lubricating drops, over an\n      eight week period. Participant's dry eye symptoms would also improve with sustained use of\n      TheraTears\u00ae lubricating drops."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Is at least 21 years of age and has full legal capacity to volunteer;\n\n          2. Has read and signed the information consent letter;\n\n          3. Is willing and able to follow instructions and maintain the appointment schedule;\n\n          4. Is diagnosed with dry eye syndrome (in at least one eye), indicated by current ocular\n             examination, prior history (self-reported history of dry eye is acceptable) and\n             current use of treatments for dry eye;\n\n          5. Has a minimum osmolarity reading of 316 mosm/kg at the baseline visit in at least one\n             eye.\n\n        Exclusion Criteria:\n\n          1. Has taken part in another research study within the last 30 days;\n\n          2. Planned contact lens wear during the course of the study;\n\n          3. Staff at the investigational site or family member of site staff or family member of\n             currently enrolled participant;\n\n          4. Any subject that violates the washout period by using eye drops during the 72hrs\n             washout period;\n\n          5. Has any known ocular disease including active ocular infection, inflammation or\n             allergy, especially Salzmann's nodular degeneration, symptomatic conjunctivochalasis,\n             and fixation disparity syndrome;\n\n          6. Used Restasis (or similar topical medication) within the last 6 months;\n\n          7. Has a systemic condition that in the opinion of the investigator may affect the dry\n             eye status of the subject, especially those newly diagnosed, newly prescribed and/or\n             unstable;\n\n          8. Is pregnant, lactating or planning a pregnancy at the time of enrolment (verbal\n             confirmation necessary);\n\n          9. Use of medications such as:  Systemic Antihistamine (e.g., Allegra\u00ae, Benadryl\u00ae,\n             Claritin\u00ae, Dimetapp\u00ae, Unisom\u00ae, Zyrtec\u00ae, etc.),  Isotretinoin (e.g., Accutane\u00ae,\n             Roaccutane\u00ae, Amnesteem\u00ae, Claravis\u00ae, Isotroin\u00ae, Sotret\u00ae) or similar medications;\n\n         10. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study;\n\n         11. Has undergone ocular surgery(LASIK, Cataract, etc)within the last year."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "35", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02100787", 
            "org_study_id": "AVR_PM_102_13"
        }, 
        "intervention": {
            "arm_group_label": "TheraTears lubricating drops", 
            "description": "A over-the-counter lubricating eye drop to be used 1 drop in both eyes 4 times a day (QID) for 8 weeks", 
            "intervention_name": "TheraTears lubricating drops", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Carboxymethylcellulose Sodium"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "tear osmolarity", 
            "keratitis sicca", 
            "ocular surface disease", 
            "TheraTears"
        ], 
        "lastchanged_date": "March 27, 2014", 
        "location": {
            "contact": {
                "email": "pam@jenkinseyecare.com", 
                "last_name": "Pamula Utu", 
                "phone": "808-591-9911"
            }, 
            "facility": {
                "address": {
                    "city": "Honolulu", 
                    "country": "United States", 
                    "state": "Hawaii", 
                    "zip": "96814"
                }, 
                "name": "Jenkins Eye Care"
            }, 
            "investigator": [
                {
                    "last_name": "Loretta T Ng, OD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Jacqueline Ueda, OD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of Tear Osmolarity Over Time With Sustained Use of TheraTears Lubricating Drops", 
        "overall_contact": {
            "email": "loritng@gmail.com", 
            "last_name": "Loretta T Ng, OD", 
            "phone": "(808) 591-9911"
        }, 
        "overall_contact_backup": {
            "email": "jacqueline@jenkinseyecare.com", 
            "last_name": "Jacqueline Ueda, OD", 
            "phone": "(808) 591-9911"
        }, 
        "overall_official": {
            "affiliation": "Jenkins Eye Care", 
            "last_name": "Loretta Ng, OD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Change in tear osmolarity", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 8 weeks"
            }, 
            {
                "description": "The OSDI is a questionnaire that the subject completes to gauge their dry eye symptoms.", 
                "measure": "Change in the Ocular Surface Disease Index (OSDI) score", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 8 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02100787"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "23402632", 
                "citation": "Keech A, Senchyna M, Jones L. Impact of time between collection and collection method on human tear fluid osmolarity. Curr Eye Res. 2013 Apr;38(4):428-36. doi: 10.3109/02713683.2013.763987. Epub 2013 Feb 12."
            }, 
            {
                "PMID": "12786773", 
                "citation": "Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Experiment Ophthalmol. 2003 Jun;31(3):229-32."
            }
        ], 
        "secondary_outcome": [
            {
                "measure": "Change in visual acuity", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 8 weeks"
            }, 
            {
                "measure": "Change in Tear Break Up Time", 
                "safety_issue": "No", 
                "time_frame": "baseline and 8 weeks"
            }, 
            {
                "measure": "Change in Phenol Red Thread test", 
                "safety_issue": "No", 
                "time_frame": "baseline and 8 weeks"
            }, 
            {
                "measure": "Change in corneal and conjunctival staining", 
                "safety_issue": "No", 
                "time_frame": "baseline and 8 weeks"
            }
        ], 
        "source": "Jenkins Eye Care", 
        "sponsors": {
            "collaborator": {
                "agency": "Advanced Vision Research", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Jenkins Eye Care", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}